242 related articles for article (PubMed ID: 30649469)
1. Effect of rituximab treatment on T and B cell subsets in lymph node biopsies of patients with rheumatoid arthritis.
Ramwadhdoebe TH; van Baarsen LGM; Boumans MJH; Bruijnen STG; Safy M; Berger FH; Semmelink JF; van der Laken CJ; Gerlag DM; Thurlings RM; Tak PP
Rheumatology (Oxford); 2019 Jun; 58(6):1075-1085. PubMed ID: 30649469
[TBL] [Abstract][Full Text] [Related]
2. Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis.
Sellam J; Rouanet S; Hendel-Chavez H; Abbed K; Sibilia J; Tebib J; Le Loët X; Combe B; Dougados M; Mariette X; Taoufik Y
Arthritis Rheum; 2011 Dec; 63(12):3692-701. PubMed ID: 22127692
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic effect of rituximab on peripheral blood B cells in rheumatoid arthritis.
Szodoray P; Alex P; Dandapani V; Nakken B; Pesina J; Kim X; Wallis GL; Wilson PC; Jonsson R; Centola M
Scand J Immunol; 2004; 60(1-2):209-18. PubMed ID: 15238091
[TBL] [Abstract][Full Text] [Related]
4. Changes of memory B- and T-cell subsets in lupus nephritis patients.
Kosalka J; Jakiela B; Musial J
Folia Histochem Cytobiol; 2016; 54(1):32-41. PubMed ID: 27094637
[TBL] [Abstract][Full Text] [Related]
5. Expanded CD23(+)/CD21(hi) B cells in inflamed lymph nodes are associated with the onset of inflammatory-erosive arthritis in TNF-transgenic mice and are targets of anti-CD20 therapy.
Li J; Kuzin I; Moshkani S; Proulx ST; Xing L; Skrombolas D; Dunn R; Sanz I; Schwarz EM; Bottaro A
J Immunol; 2010 Jun; 184(11):6142-50. PubMed ID: 20435928
[TBL] [Abstract][Full Text] [Related]
6. Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis.
Rehnberg M; Amu S; Tarkowski A; Bokarewa MI; Brisslert M
Arthritis Res Ther; 2009; 11(4):R123. PubMed ID: 19686595
[TBL] [Abstract][Full Text] [Related]
7. The cellular composition of lymph nodes in the earliest phase of inflammatory arthritis.
van Baarsen LG; de Hair MJ; Ramwadhdoebe TH; Zijlstra IJ; Maas M; Gerlag DM; Tak PP
Ann Rheum Dis; 2013 Aug; 72(8):1420-4. PubMed ID: 23661491
[TBL] [Abstract][Full Text] [Related]
8. Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response.
Nakou M; Katsikas G; Sidiropoulos P; Bertsias G; Papadimitraki E; Raptopoulou A; Koutala H; Papadaki HA; Kritikos H; Boumpas DT
Arthritis Res Ther; 2009; 11(4):R131. PubMed ID: 19715572
[TBL] [Abstract][Full Text] [Related]
9. Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis.
Roll P; Palanichamy A; Kneitz C; Dorner T; Tony HP
Arthritis Rheum; 2006 Aug; 54(8):2377-86. PubMed ID: 16869000
[TBL] [Abstract][Full Text] [Related]
10. B-cell phenotype and IgD-CD27- memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis.
Moura RA; Quaresma C; Vieira AR; Gonçalves MJ; Polido-Pereira J; Romão VC; Martins N; Canhão H; Fonseca JE
PLoS One; 2017; 12(9):e0182927. PubMed ID: 28886017
[TBL] [Abstract][Full Text] [Related]
11. IL-40: A New B Cell-Associated Cytokine Up-Regulated in Rheumatoid Arthritis Decreases Following the Rituximab Therapy and Correlates With Disease Activity, Autoantibodies, and NETosis.
Navrátilová A; Andrés Cerezo L; Hulejová H; Bečvář V; Tomčík M; Komarc M; Veigl D; Tegzová D; Závada J; Olejárová M; Pavelka K; Vencovský J; Šenolt L
Front Immunol; 2021; 12():745523. PubMed ID: 34745117
[TBL] [Abstract][Full Text] [Related]
12. Expansion of Activated Peripheral Blood Memory B Cells in Rheumatoid Arthritis, Impact of B Cell Depletion Therapy, and Biomarkers of Response.
Adlowitz DG; Barnard J; Biear JN; Cistrone C; Owen T; Wang W; Palanichamy A; Ezealah E; Campbell D; Wei C; Looney RJ; Sanz I; Anolik JH
PLoS One; 2015; 10(6):e0128269. PubMed ID: 26047509
[TBL] [Abstract][Full Text] [Related]
13. The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment.
Cambridge G; Perry HC; Nogueira L; Serre G; Parsons HM; De La Torre I; Dickson MC; Leandro MJ; Edwards JC
J Autoimmun; 2014 May; 50():67-76. PubMed ID: 24365380
[TBL] [Abstract][Full Text] [Related]
14. B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status.
Michelutti A; Gremese E; Morassi F; Petricca L; Arena V; Tolusso B; Alivernini S; Peluso G; Bosello SL; Ferraccioli G
Mol Med; 2011; 17(9-10):901-9. PubMed ID: 21607290
[TBL] [Abstract][Full Text] [Related]
15. The changes of intestinal flora and its relevance with memory Tfh and B cells in rheumatoid arthritis patients treated with csDMARDs and csDMARDs + bDMARDs.
Jiang C; Chi S; Wang F; Zhao C; Yang X; Liu M; Ma B; Chen J; Su C; Duan X
Immunobiology; 2024 May; 229(3):152798. PubMed ID: 38537424
[TBL] [Abstract][Full Text] [Related]
16. CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritis.
Sellam J; Rouanet S; Hendel-Chavez H; Miceli-Richard C; Combe B; Sibilia J; Le Loët X; Tebib J; Jourdan R; Dougados M; Taoufik Y; Mariette X
Arthritis Rheum; 2013 Sep; 65(9):2253-61. PubMed ID: 23740460
[TBL] [Abstract][Full Text] [Related]
17. Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor.
Souto-Carneiro MM; Mahadevan V; Takada K; Fritsch-Stork R; Nanki T; Brown M; Fleisher TA; Wilson M; Goldbach-Mansky R; Lipsky PE
Arthritis Res Ther; 2009; 11(3):R84. PubMed ID: 19500335
[TBL] [Abstract][Full Text] [Related]
18. Increased numbers of CD23(+) CD21(hi) Bin-like B cells in human reactive and rheumatoid arthritis lymph nodes.
Kuzin II; Kates SL; Ju Y; Zhang L; Rahimi H; Wojciechowski W; Bernstein SH; Burack R; Schwarz EM; Bottaro A
Eur J Immunol; 2016 Jul; 46(7):1752-7. PubMed ID: 27105894
[TBL] [Abstract][Full Text] [Related]
19. Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response.
Thurlings RM; Vos K; Wijbrandts CA; Zwinderman AH; Gerlag DM; Tak PP
Ann Rheum Dis; 2008 Jul; 67(7):917-25. PubMed ID: 17965121
[TBL] [Abstract][Full Text] [Related]
20. Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment.
Roll P; Dörner T; Tony HP
Arthritis Rheum; 2008 Jun; 58(6):1566-75. PubMed ID: 18512772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
